v3.25.4
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Noncash Investing and Financing Items [Abstract]        
Income Taxes Paid, Net $ 846 $ 1,093 $ (537)  
Capital Expenditures Incurred but Not yet Paid 113 1,047 214  
Proceeds from Issuance or Sale of Equity 0 999 0  
Operating activities:        
Net loss (93,487) (432,311) (53,183)  
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization 7,065 6,491 6,160  
operating lease, right-of-use asset, periodic reduction, net 3,265 1,050 3,090  
Stock-based compensation 19,542 29,132 41,479  
Goodwill, Impairment Loss 18,600 0 0  
Deferred income taxes, net 280 296,771 (17,891)  
Operating Lease, Impairment Loss 0 3,276 0  
Gain (Loss) on Extinguishment of Debt 0 0 (3,092)  
Other 1,537 461 (2,600)  
Changes in operating assets and liabilities:        
Accounts receivable, net (7,297) 5,291 (14,478)  
Inventory 42,285 (14,450) 20,865  
Prepaid expenses and other assets 2,798 1,080 (7,649)  
Accounts payable and other liabilities (11,134) (21,162) (4,226)  
Deferred revenue (4,123) (770) (1,338)  
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation (20,669) (125,141) (32,863)  
Investing activities:        
Purchases of property and equipment, net (3,362) (4,039) (1,520)  
Purchases of marketable securities 0 0 (25,782)  
Maturities of marketable securities 0 24,000 149,204  
Payments to Acquire Businesses, Net of Cash Acquired 0 12,308 0  
Net cash provided by (used in) investing activities (3,362) 7,653 121,902  
Financing activities:        
Proceeds from issuance of common stock 2,706 2,150 3,876  
Payment, Tax Withholding, Share-based Payment Arrangement (1,916) (3,079) (8,008)  
Payments for Repurchase of Common Stock 0 0 (40,000)  
Early Repayment of Senior Debt (93,750) 0 (46,250)  
Proceeds from Lines of Credit 113,174 0 0  
Repayments of Lines of Credit (48,044) 0 0  
Payments of Debt Issuance Costs (2,282) 0 0  
Net cash used in financing activities (30,112) (929) (90,382)  
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1,006 (1,480) 316  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (53,137) (119,897) (1,027)  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents   102,811 222,708 $ 223,735
Cash and cash equivalents 49,674 102,811 222,708  
Interest Paid, Excluding Capitalized Interest, Operating Activity $ 4,310 $ 1,286 $ 1,976